metricas
covid
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
ISSN: 2253-8089

The Revista Española de Medicina Nuclear e Imagen Molecular (Spanish Journal of Nuclear Medicine and Molecular Imaging), was founded in 1982, and is the official journal of the Spanish Society of Nuclear Medicine and Molecular Imaging.
The Journal, which publishes six regular issues per year, is committed to fostering research and advancing continuing education across all domains of Nuclear Medicine. Its main sections include Original Articles, Images of Interest, and Special Collaboration papers. Manuscripts may be submitted in either Spanish or English and are subject to a rigorous peer-review process prior to publication.

See more Open Access Option

Indexed in:

Medline

See more

Follow us:

Subscribe:

tienda
Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more
Impact factor 2024
1.0
Citescore

CiteScore measures average citations received per document published.

See more
Citescore 2024
0.9
SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2024
0.216
SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2024
0.216
View more metrics
Hide
Issue
portada-S2253808925X00069Vol. 44. Issue 6.
(November - December 2025)
Editorial
One year of key contributions by the SEMNIM Oncology Group
M. Rodríguez-Fraile
Rev Esp Med Nucl Imagen Mol. 2025;44:
Original articles
Comparison of 99mTc-HYNIC-PSMA-11, bone scan and post radioligand therapy images in mCRPC patients: A single center experience
K. Aryana, A. Aghaee, E. Askari, Y. Fakhar, N. Raeisi, M. Mottaghi, M. Emadzadeh, H. Ghorbani, S. Barashki
Rev Esp Med Nucl Imagen Mol. 2025;44:
Clinical course and features of thyroid oncocytic (Hurthle cell) cancer: Comparison with thyroid follicular cancer
K. Okuyucu, U.M. Turan, P. Akkus Gunduz, M. Ozkara, N. Aydinbelge Dizdar, A. Cinar, M. Samsum, P. Sahin Oguz, ... S. Ince
Rev Esp Med Nucl Imagen Mol. 2025;44:
Staging in nasopharynx cancers prognostic value of volumetric parameters in [18F]FDG PET/CT imaging
Ç. Erol, Ö. Şahin, G. Kanyılmaz, S. Erol
Rev Esp Med Nucl Imagen Mol. 2025;44:
Adverse reactions mediated by 99mTc-tetrofosmin: Literature review and analysis of post-marketing reports
S. Martins, S. Costa, M. Sousa, F. Moreira, A. Martín-Suaréz, Â. Jesus
Rev Esp Med Nucl Imagen Mol. 2025;44:
Interesting images
Contribution of 123-I in Peritoneal Strumosis
L. Delgado Niño, J. Romero Martínez, F. Martín Ordoñez
Rev Esp Med Nucl Imagen Mol. 2025;44:
SPECT/CT with 99mTc-sestamibi in the diagnosis of renal masses
L. Pinilla, E. Riera, J.R. García, L.I. Mont-Castro, M. Soria, E. Valls
Rev Esp Med Nucl Imagen Mol. 2025;44:
Aggressive ductal carcinoma presented with bilateral breast superscan on [18F]FDG PET/CT
Ahmed S. Abdlkadir, Enrique Estrada-Lobato, Kamal Al-Rabi, Akram Al-Ibraheem
Rev Esp Med Nucl Imagen Mol. 2025;44:
68Ga-FAPI and 18F-FDG PET/CT: Complementary imaging modalities for detecting unusual metastasis in a patient with osteosarcoma
G.A. Divband, E. Askari, H.R. Amini, A.R. Noferesti, P. Sahafi
Rev Esp Med Nucl Imagen Mol. 2025;44:
Continuing education
PET/CT in breast cancer
J.F. Bastidas, M. Martínez de Bourio-Allona, A. Roteta Unceta Barrenechea, M. Rodríguez-Fraile, L. Sancho
Rev Esp Med Nucl Imagen Mol. 2025;44:
Letter to the editor